Table 3.
Group | N | Mean | Median | Mininum | Maximum | SD | p-value | |
---|---|---|---|---|---|---|---|---|
TNF-α (ng ml–1) | SK | 10 | 3.08 | 3.37 | 2.02 | 4.10 | 0.76 | 0.0095 |
SH2 | 10 | 2.63 | 2.70 | 2.00 | 3.20 | 0.36 | ||
SH4 | 10 | 2.20 | 1.98 | 1.76 | 2.91 | 0.43 | ||
CRP (ng ml–1) | SK | 10 | 82.20 | 83.50 | 75.00 | 87.00 | 3.77 | 0.07 |
SH2 | 10 | 79.80 | 79.50 | 76.00 | 84.00 | 2.74 | ||
SH4 | 10 | 78.70 | 78.50 | 75.00 | 84.00 | 3.16 | ||
TAS (mM) | SK | 10 | 1.09 | 0.95 | 0.88 | 1.60 | 0.27 | 0.0001 |
SH2 | 10 | 1.69 | 1.80 | 1.22 | 1.93 | 0.25 | ||
SH4 | 10 | 2.23 | 2.23 | 2.08 | 2.31 | 0.07 |
CRP levels in all groups were consistent with normal distribution (Shapiro–Wilk test). Part of TNF-α and TAS levels were not consistent with a normal distribution (Shapiro–Wilk test). TNF-α, tumor necrosis factor; CRP, C-reactive protein; TAS, plasma total antioxidant status; SD, standard deviation.